Anwar Khurshid, MD - Medicare Medical Oncology in Arlington, TX

Anwar Khurshid, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Arlington, Texas. He graduated from medical school in 1989 and has 35 years of diverse experience with area of expertise as Medical Oncology. He is a member of the group practice Texas Oncology Pa and his current practice location is 906 W Randol Mill Rd, Arlington, Texas. You can reach out to his office (for appointments etc.) via phone at (817) 261-4906.

Anwar Khurshid is licensed to practice in Texas (license number K3278) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1922000488.

Contact Information

Anwar Khurshid, MD
906 W Randol Mill Rd,
Arlington, TX 76012-2510
(817) 261-4906
Not Available



Physician's Profile

Full NameAnwar Khurshid
GenderMale
SpecialityMedical Oncology
Experience35 Years
Location906 W Randol Mill Rd, Arlington, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Anwar Khurshid graduated from medical school in 1989
  NPI Data:
  • NPI Number: 1922000488
  • Provider Enumeration Date: 08/15/2005
  • Last Update Date: 10/05/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 7719961952
  • Enrollment ID: I20040616000052

Medical Identifiers

Medical identifiers for Anwar Khurshid such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1922000488NPI-NPPES
154897609MedicaidTX
154897605MedicaidTX
154897604MedicaidTX
154897603MedicaidTX
154897601MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology SP-4 (Alabama)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 80500 (Massachusetts)Secondary
207RH0003XInternal Medicine - Hematology & Oncology K3278 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Texas Health Arlington Memorial HospitalArlington, TXHospital
Methodist Mansfield Medical CenterMansfield, TXHospital
Medical City ArlingtonArlington, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Texas Oncology Pa5395658934855

News Archive

Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.

LLNL-developed thin-film electrodes generate never-before-seen recordings of brain activity

Thin-film electrodes developed at Lawrence Livermore National Laboratory have been used in human patients at the University of California, San Francisco, generating never-before-seen recordings of brain activity in the hippocampus, a region responsible for memory and other cognitive functions.

Breast cancer screening situation will get worse

According to a recently published study, community-based mammography facilities do not have enough radiologists and certified technologists to adequately deliver screening and diagnostic services to the public, and the situation will probably get worse.

Urine proteome pattern may predict coronary artery disease

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.

Restored Hearing to launch clinical trials to find cure for permanent tinnitus

Restored Hearing, a company established by physics students from University College Dublin and the University of Edinburgh, is preparing to launch a series of clinical trials in Edinburgh to see if its 'sound therapy' for temporary tinnitus can be used to treat a more serious permanent 'ringing in the ears'.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Anwar Khurshid allows following entities to bill medicare on his behalf.
Entity NameTexas Oncology Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811944101
PECOS PAC ID: 5395658934
Enrollment ID: O20031124000323

News Archive

Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.

LLNL-developed thin-film electrodes generate never-before-seen recordings of brain activity

Thin-film electrodes developed at Lawrence Livermore National Laboratory have been used in human patients at the University of California, San Francisco, generating never-before-seen recordings of brain activity in the hippocampus, a region responsible for memory and other cognitive functions.

Breast cancer screening situation will get worse

According to a recently published study, community-based mammography facilities do not have enough radiologists and certified technologists to adequately deliver screening and diagnostic services to the public, and the situation will probably get worse.

Urine proteome pattern may predict coronary artery disease

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.

Restored Hearing to launch clinical trials to find cure for permanent tinnitus

Restored Hearing, a company established by physics students from University College Dublin and the University of Edinburgh, is preparing to launch a series of clinical trials in Edinburgh to see if its 'sound therapy' for temporary tinnitus can be used to treat a more serious permanent 'ringing in the ears'.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anwar Khurshid is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Anwar Khurshid, MD
Po Box 911230,
Dallas, TX 75391-1230

Ph: (972) 997-8000
Anwar Khurshid, MD
906 W Randol Mill Rd,
Arlington, TX 76012-2510

Ph: (817) 261-4906

News Archive

Veracyte launches new genomic test to improve lung cancer diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, today announced the launch of its Percepta Bronchial Genomic Classifier, a new genomic test to resolve ambiguity in lung cancer diagnosis. The company will soon begin testing patient samples in its CLIA-certified laboratory, with the Percepta test now available to a limited number of institutions around the country.

LLNL-developed thin-film electrodes generate never-before-seen recordings of brain activity

Thin-film electrodes developed at Lawrence Livermore National Laboratory have been used in human patients at the University of California, San Francisco, generating never-before-seen recordings of brain activity in the hippocampus, a region responsible for memory and other cognitive functions.

Breast cancer screening situation will get worse

According to a recently published study, community-based mammography facilities do not have enough radiologists and certified technologists to adequately deliver screening and diagnostic services to the public, and the situation will probably get worse.

Urine proteome pattern may predict coronary artery disease

Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.

Restored Hearing to launch clinical trials to find cure for permanent tinnitus

Restored Hearing, a company established by physics students from University College Dublin and the University of Edinburgh, is preparing to launch a series of clinical trials in Edinburgh to see if its 'sound therapy' for temporary tinnitus can be used to treat a more serious permanent 'ringing in the ears'.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in Arlington, TX

Dr. Waldo P Bracy Jr., M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012
Phone: 817-394-4300    Fax: 817-394-0200
Thang D Le, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012
Phone: 866-202-1032    Fax: 817-548-6649
Dr. Hujefa Yusuf Vora, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015
Phone: 817-784-0052    Fax: 817-375-5800
Dr. Raza Askari,
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014
Phone: 817-375-5847    
Thuc Quyen Thi Nguyen,
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014
Phone: 817-417-4027    Fax: 817-417-4043
Dr. Bienvenido Gatmaitan Gatmaitan,
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015
Phone: 817-860-6062    Fax: 817-795-6652
Bernard A Mcgowen, MD
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015
Phone: 817-419-9155    Fax: 817-419-9412

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.